Status:
Ready to upload
Record number:
1288
Adverse Occurrence type:
MPHO Type:
Estimated frequency:
0.29% in platelet prepared with additive solutions vs. 0.82% (plasma) per platelet transfusion; per patient the incidence was 0.83% versus 3.13%, respectively.
Alerting signals, symptoms, evidence of occurrence:
Per National Healthcare Safety Network criteria. Active surveillance for transfusion adverse events was conducted by blinded observers.
Demonstration of imputability or root cause:
Retrospective review.
Imputability grade:
2 Probable
Groups audience:
Keywords:
Reference attachment:
Suggest references:
Cohn, C.S., Stubbs, J., Schwartz, J., Francis, R., Goss, C., Cushing, M., Shaz, B., Mair, D., Brantigan, B. and Heaton, A. (2014). A comparison of adverse reaction rates for PAS C versus plasma platelet units. Transfusion54:1927-1934.